The clinical results seen with the patented INR anti-TNF treatment methods for stroke, Alzheimer’s disease, and sciatica are unprecedented[1-10]. Their scientific basis depends on the fact that the INR approach directly targets TNF, an immune signaling molecule present in excess in neuroinflammatory conditions. The following videos are included to help illustrate the range of clinical effects that may occur following initiation of anti-TNF treatment at the INR. All videos are of actual INR patients, depicting their actual results, with commentary by their family members. For further information please see the following INR websites:
The INR Sciatica and Back Pain website
The INR Alzheimer’s Disease website
Disclaimer: Individual results vary, not all patients respond. Repeated dosing is necessary for optimal effect. Anti-TNF treatment for the indications below is off-label. Please see the Terms of Use. The methods of local anti-TNF treatment utilized for these patients are patented inventions of the INR.
Rapid improvement in walking abilities, more than ten years after stroke following the INR’s patented local etanercept treatment is documented. Discussion is by the patient’s son, a physician,... View Video
Husband and wife discuss improvements following local administration of etanercept at the INR in Los Angeles years after stroke. This new patented treatment, invented by Dr. Tobinick, is available for... View Video
Rapid improvement following anti-TNF treatment at the INR is seen. The patient is able to recognize his wife for the first time in years within minutes after treatment. Also seen is his improvement in... View Video
Son comments on the immediate difference he saw after the first dose of his father’s anti-TNF treatment. This video documents the unprecendented rapid improvement that may occur after initiation... View Video
A retired military officer is brought to the INR by his son for treatment of progressive Alzheimer’s disease. He is seen before and after anti-TNF treatment, and his improvements are visible and... View Video